Federal Register #2026-20113

DEA information collections for controlled-substance records and order forms

The Department of Justice’s Drug Enforcement Administration is requesting continued authorization for several controlled-substance information collections, not seeking products or services through a procurement. - Government buyer: Department of Justice (DOJ), Drug Enforcement Administration (DEA), Diversion Control Division / Office of Diversion Control. - Information collections described: - Electronic prescription transfers between pharmacies for initial filling: recordkeeping covering pharmacy and pharmacist names, pharmacy addresses, DEA registration numbers, and transfer dates. Estimated 66,088 registrants, 12,900,000 annual responses, and 645,000 annual burden hours. - U.S. Official Order Forms for Schedules I and II controlled substances: paper DEA Form 222 and online DEA-222/CSOS submissions. Estimated 114,989 registrants, 15,742,214 annual responses, and 1,624,529 annual burden hours. - Recordkeeping for partial fills of prescriptions: a proposed revision to an existing information collection; further details are not provided. - OEMs and vendors: None identified. DEA Form 222 and CSOS are forms or submission systems, not named commercial vendors. - Procurement status: No products or services are being solicited for purchase; product quantities and contract value are not applicable.

Description

The Drug Enforcement Administration (DEA), within the Department of Justice, is seeking reinstatement without change of a previously approved information collection for U.S. Official Order Forms for Schedules I and II Controlled Substances (DEA Form 222). The collection concerns the forms used under the Controlled Substances Act for the distribution of Schedule I and II controlled substances. The DEA estimates 114,989 registrants will participate, with an estimated annual burden of 1,624,529 hours and no other annual costs. Comments are due November 2, 2026.

View original listing